Table 2—

Age-adjusted BMI and prevalence of the metabolic syndrome (or individual metabolic disorders) in nondiabetic participants aged 35–64 years

CharacteristicLima, PeruMexico CitySan Antonio Mexican AmericansSan Antonio non-Hispanic whitesSpain
Men
    BMI (kg/m2)26.5 ± 0.427.0 ± 0.128.8 ± 0.227.7 ± 0.227.4 ± 0.1
    Elevated waist circumference using ATP III cutoff points15.4 (9.7–23.7)16.0 (13.7–18.7)28.7 (25.4–32.4)33.7 (29.3–38.5)22.1 (19.8–24.6)
    Elevated waist circumference using IDF cutoff points63.4 (53.7–72.2)66.4 (63.0–69.5)78.2 (74.8–81.3)65.5 (60.7–70.1)54.7 (51.8–57.6)
    Hypertriglyceridemia38.3 (29.5–47.9)69.6 (66.3–72.7)49.7 (45.8–53.5)39.8 (35.1–44.7)29.7 (27.1–32.4)
    Low HDL cholesterol levels25.7 (18.3–35.0)88.6 (86.3–90.6)56.4 (52.5–60.2)58.4 (53.5–63.2)30.8 (28.2–33.6)
    High blood pressure30.7 (22.4–40.4)30.9 (27.7–34.3)40.1 (36.3–44.1)32.9 (28.4–37.7)46.3 (43.3–49.3)
    Elevated fasting glucose levels19.3 (12.8–28.1)12.0 (10.0–14.5)21.6 (18.6–24.9)15.8 (12.6–19.7)28.3 (25.8–31.0)
    ATP III–defined metabolic syndrome11.6 (6.7–19.3)32.6 (29.4–35.9)32.0 (28.5–35.7)28.5 (24.3–33.1)22.0 (19.7–24.5)
    IDF-defined metabolic syndrome26.1 (18.5–32.3)55.6 (52.1–59.0)45.8 (41.9–49.7)37.3 (32.7–42.1)27.3 (24.8–30.0)
Women
    BMI (kg/m2)27.3 ± 0.328.9 ± 0.129.2 ± 0.226.4 ± 0.227.9 ± 0.1
    Elevated waist circumference using ATP III cutoff points60.8 (54.4–66.9)81.0 (78.6–83.1)57.5 (54.2–60.8)39.9 (35.6–44.3)64.1 (61.5–66.6)
    Elevated waist circumference using IDF cutoff points85.5 (80.8–89.2)94.4 (93.0–95.5)78.5 (75.6–81.0)62.9 (58.4–67.1)85.9 (84.0–87.7)
    Hypertriglyceridemia36.7 (30.7–43.2)54.9 (52.0–57.8)36.1 (33.0–39.3)26.5 (22.9–30.5)12.2 (10.6–14.0)
    Low HDL cholesterol levels33.7 (28.0–39.9)94.2 (92.7–95.4)61.9 (58.7–65.0)54.9 (50.5–59.2)35.8 (33.4–38.4)
    High blood pressure25.3 (19.8–31.7)26.7 (24.1–29.6)27.7 (24.8–30.8)23.5 (20.0–27.5)44.9 (42.1–47.7)
    Elevated fasting glucose levels23.0 (18.0–28.8)13.2 (11.4–15.3)15.2 (13.0–17.6)8.8 (6.7–11.6)21.0 (18.9–23.2)
    ATP III–defined metabolic syndrome27.3 (21.8–33.6)59.2 (56.3–62.1)34.2 (31.1–37.4)22.7 (19.3–26.6)28.8 (26.4–31.2)
    IDF-defined metabolic syndrome30.0 (24.3–36.4)64.0 (61.2–66.8)39.3 (36.1–42.5)25.7 (22.0–29.6)31.7 (29.3–34.2)
  • Data are means ± SE or % (95% CI).